Literature DB >> 10984067

Stressor-specific activation of the hypothalamic-pituitary-adrenocortical axis.

K Pacák1.   

Abstract

New information has accrued from in vivo microdialysis studies about stress-related changes in norepinephrine concentrations in extracellular fluid of the paraventricular nucleus (PVN) and the activation of the hypothalamic-pituitary-adrenocortical (HPA) axis. Our data on the effects of lower brainstem hemisections show that paraventricular noradrenergic terminals are derived mainly from medullary A1 and A2 catecholaminergic cells. The activation of these cells contributes importantly to stress-induced noradrenergic activation in the paraventricular nucleus of conscious animals. The results from brainstem hemisection experiments also indicate that baseline levels and immobilization-induced increments in corticotropin-releasing hormone (CRH) mRNA expression in the PVN depend on ipsilaterally ascending medullary tract. Thus, the prevalent concept that stress-induced noradrenergic activation of the HPA axis depends mainly on activation of locus ceruleus noradrenergic neurons requires re-evaluation. Our new stress concepts favor stressor-specific activation of the HPA axis. The present data also suggest the existence of stressor-specific central pathways that differentially participate in the regulation of sympathoneuronal and adrenomedullary outflows as well as of the activity of the HPA axis. Furthermore, the results are inconsistent with a founding tenet of Selye's stress theory, the doctrine of nonspecificity, which defines stress as the nonspecific response of the body to any demand. We expect that future studies in this area will focus on further examination of the notion of stressor-specific patterns of central neurotransmitter release and elucidate the genetic bases of these patterns.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10984067

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  13 in total

Review 1.  Paraventricular nucleus, stress response, and cardiovascular disease.

Authors:  Eduardo E Benarroch
Journal:  Clin Auton Res       Date:  2005-08       Impact factor: 4.435

2.  Stressor-specific alterations in corticosterone and immune responses in mice.

Authors:  Stephanie L Bowers; Staci D Bilbo; Firdaus S Dhabhar; Randy J Nelson
Journal:  Brain Behav Immun       Date:  2007-09-24       Impact factor: 7.217

Review 3.  Concepts of scientific integrative medicine applied to the physiology and pathophysiology of catecholamine systems.

Authors:  David S Goldstein
Journal:  Compr Physiol       Date:  2013-10       Impact factor: 9.090

4.  Behavioral effects of local microinfusion of pituitary adenylate cyclase activating polypeptide (PACAP) into the paraventricular nucleus of the hypothalamus (PVN).

Authors:  Seth D Norrholm; Mahasweta Das; Gábor Légrádi
Journal:  Regul Pept       Date:  2005-05-15

5.  Voluntary exercise regionally augments rates of cerebral protein synthesis.

Authors:  Jeffrey Nadel; Tianjian Huang; Zengyan Xia; Thomas Burlin; Alan Zametkin; Carolyn Beebe Smith
Journal:  Brain Res       Date:  2013-09-07       Impact factor: 3.252

Review 6.  Effects of psychological stress on male fertility.

Authors:  Vinod H Nargund
Journal:  Nat Rev Urol       Date:  2015-06-09       Impact factor: 14.432

7.  Postmortem biochemistry and immunohistochemistry of chromogranin A as a stress marker with special regard to fatal hypothermia and hyperthermia.

Authors:  Chiemi Yoshida; Takaki Ishikawa; Tomomi Michiue; Li Quan; Hitoshi Maeda
Journal:  Int J Legal Med       Date:  2009-09-17       Impact factor: 2.686

Review 8.  Pain and stress in a systems perspective: reciprocal neural, endocrine, and immune interactions.

Authors:  C Richard Chapman; Robert P Tuckett; Chan Woo Song
Journal:  J Pain       Date:  2007-12-21       Impact factor: 5.820

Review 9.  Gonadal steroid hormones and the hypothalamo-pituitary-adrenal axis.

Authors:  Robert J Handa; Michael J Weiser
Journal:  Front Neuroendocrinol       Date:  2013-11-16       Impact factor: 8.606

10.  The combined propranolol/TSST paradigm--a new method for psychoneuroendocrinology.

Authors:  Julie Andrews; Jens C Pruessner
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.